Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H12O5 |
| Molecular Weight | 272.2528 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=C(C=C1)[C@@H]2CC(=O)C3=C(O)C=C(O)C=C3O2
InChI
InChIKey=FTVWIRXFELQLPI-ZDUSSCGKSA-N
InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2/t13-/m0/s1
| Molecular Formula | C15H12O5 |
| Molecular Weight | 272.2528 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Naringenin is one of the most abundant flavonoids in natural citrus fruits and has been studied as an antioxidant and anti-inflammatory agent. Besides, it has been investigated for its ability to inhibit the growth of breast, colon, gastric and prostate cancer cells. Experiments on rodents have revealed, that naringenin is a component of Drynaria Rhizome and can enhance memory function and ameliorate Alzheimer's disease pathologies. Using the experimental autoimmune encephalomyelitis, a rodent model of human multiple sclerosis was determined that naringenin may have a potential to ameliorate autoimmune disease by favorably modulating autoimmune response. The precise mechanism of action of naringenin compound is not clear, but it is known, that it is a partial agonist of estrogen receptor that can act as a competitive antagonist in the presence of a potent (or full) agonist. In addition, it binds to collapsin response mediator protein 2 protein (CRMP2) and reduces the Aβ-induced phosphorylation of CRMP2, resulting in axonal growth facilitation.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28674493
Curator's Comment: Known to be CNS penetrant in mice. Human data not available
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Q16555 Gene ID: 1808.0 Gene Symbol: DPYSL2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/28674493 |
|||
Target ID: CHEMBL2093866 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24260594 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Palliative | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Antifungal flavanones and prenylated hydroquinones from Piper crassinervium Kunth. | 2003-09 |
|
| Flavanone 3-hydroxylase expression in Citrus paradisi and Petunia hybrida seedlings. | 2003-09 |
|
| Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants. | 2003-09 |
|
| Xanthones and benzophenones from the stems of Garcinia multiflora. | 2003-08 |
|
| Antioxidant chalcone glycosides and flavanones from Maclura (Chlorophora) tinctoria. | 2003-08 |
|
| Separation of some chiral flavanones by micellar electrokinetic chromatography. | 2003-08 |
|
| New potent antioxidative hydroxyflavanones produced with Aspergillus saitoi from flavanone glycoside in citrus fruit. | 2003-07 |
|
| Simultaneous detection of the antioxidant and pro-oxidant activity of dietary polyphenolics in a peroxidase system. | 2003-07 |
|
| Cloning and expression of the isoflavone synthase gene (IFS-Tp) from Trifolium pratense. | 2003-06-30 |
|
| Divergent evolution of flavonoid 2-oxoglutarate-dependent dioxygenases in parsley. | 2003-06-05 |
|
| Influence of solvents on the antioxidant property of flavonoids. | 2003-06 |
|
| Pro-oxidative properties of flavonoids in human lymphocytes. | 2003-06 |
|
| Cell-specific activation of aflatoxin B1 correlates with presence of some cytochrome P450 enzymes in olfactory and respiratory tissues in horse. | 2003-06 |
|
| Naringenin inhibits phosphoinositide 3-kinase activity and glucose uptake in 3T3-L1 adipocytes. | 2003-05-30 |
|
| Degradation of flavonoid aglycones by rabbit, rat and human fecal flora. | 2003-05 |
|
| Phenolic extractives in Salix caprea wood and knots. | 2003-05 |
|
| Activation of the aryl hydrocarbon receptor by some vegetable constituents determined using in vitro reporter gene assay. | 2003-04 |
|
| Muscanone: a 3-O-(1", 8", 14"-trimethylhexadecanyl)naringenin from Commiphora wightii. | 2003-04 |
|
| Interaction between flavonoids and the blood-brain barrier: in vitro studies. | 2003-04 |
|
| [Grapefruit juice and drugs: a hazardous combination?]. | 2003-03-04 |
|
| The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid Naringenin. | 2003-03 |
|
| Glycosyl flavonoids from the roots and rhizomes of Asarum longerhizomatosum. | 2003-03 |
|
| Comparison of in vitro hepatic models for the prediction of metabolic interaction between simvastatin and naringenin. | 2003-02-18 |
|
| Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation. | 2003-02-11 |
|
| Naringenin 7-O-cetyl ether as inhibitor of HMG-CoA reductase and modulator of plasma and hepatic lipids in high cholesterol-fed rats. | 2003-02-06 |
|
| Bioflavonoids attenuate renal proximal tubular cell injury during cold preservation in Euro-Collins and University of Wisconsin solutions. | 2003-02 |
|
| Flavonol synthase from Citrus unshiu is a bifunctional dioxygenase. | 2003-02 |
|
| O-demethylation and sulfation of 7-methoxylated flavanones by Cunninghamella elegans. | 2003-02 |
|
| Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. | 2003-02 |
|
| In vitro inhibition of simvastatin metabolism, a HMG-CoA reductase inhibitor in human and rat liver by bergamottin, a component of grapefruit juice. | 2003-01 |
|
| Liquid chromatographic/electrospray ionization tandem mass spectrometric study of the phenolic composition of cocoa (Theobroma cacao). | 2003-01 |
|
| Anti-Sindbis activity of flavanones hesperetin and naringenin. | 2003-01 |
|
| Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). | 2003-01 |
|
| Polyphenol pattern and antioxidant activity of different tomato lines and cultivars. | 2003 |
|
| Problems for risk assessment of endocrine-active estrogenic compounds. | 2002-12 |
|
| Flavonoids and nitric oxide synthase. | 2002-12 |
|
| Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. | 2002-11 |
|
| Molecular characterization of root-specific chalcone synthases from Cassia alata. | 2002-11 |
|
| Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. | 2002-11 |
|
| Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9. | 2002-11 |
|
| Fasting plasma concentrations of selected flavonoids as markers of their ordinary dietary intake. | 2002-10 |
|
| High-flavonol tomatoes resulting from the heterologous expression of the maize transcription factor genes LC and C1. | 2002-10 |
|
| Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. | 2002-09-25 |
|
| Liquid chromatographic-photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood. | 2002-09-25 |
|
| Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters. | 2002-09 |
|
| Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. | 2002-09 |
|
| Enantiomer separation of flavour and fragrance compounds by liquid chromatography using novel urea-covalent bonded methylated beta-cyclodextrins on silica. | 2002-08-30 |
|
| Free radical scavengers from the heartwood of Juniperus chinensis. | 2002-08 |
|
| Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids. | 2002-07 |
|
| Preincubation of Mesorhizobium ciceri with flavonoids improves its nodule occupancy. | 2002 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28674493
orally administered a high dose of Drynaria Rhizome (DR) (13 g kg-1) to the 5XFAD mice. Naringenin was present at 0.27 mg g-1 in DR extract
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29411263
Naringenin (NGN) induced anti-inflammatory effects in paraquat (PQ)-treated SH-SY5Y cells by a mechanism associated with the Nrf2/HO-1 signaling pathway. Pretreatment with NGN at 80 µM for 2 h decreased the levels of pro-inflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in PQ-treated SH-SY5Y cells. The production of nitric oxide (NO·) and levels of cyclooxygenase-2 (COX-2) and of the inducible isoform of nitric oxide synthase (iNOS) were downregulated by NGN in the cells exposed to PQ. Moreover, NGN downregulated the activation of the nuclear factor-κB (NF-κB) in PQ-treated cells.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:09:04 GMT 2025
by
admin
on
Mon Mar 31 18:09:04 GMT 2025
|
| Record UNII |
HN5425SBF2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
529 (Number of products:113)
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
34875
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | |||
|
C005273
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | |||
|
11855
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | |||
|
C68463
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | |||
|
HN5425SBF2
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | |||
|
1368173
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | RxNorm | ||
|
HN5425SBF2
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | |||
|
DTXSID1022392
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | |||
|
439246
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | |||
|
300000051275
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | |||
|
480-41-1
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | |||
|
m7776
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB03467
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | |||
|
207-550-2
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | |||
|
NARINGENIN
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY | |||
|
17846
Created by
admin on Mon Mar 31 18:09:04 GMT 2025 , Edited by admin on Mon Mar 31 18:09:04 GMT 2025
|
PRIMARY |